Michelson expands OCT focus to tissue engineering, developmental biology

OCTOBER 2, 2008 -- Michelson Diagnostics Ltd (MDL; Kent, UK) says it is broadening the commercial application of its multi-beam optical coherence tomography (OCT) technology into markets beyond its core target, the detection and diagnosis of various cancer forms. MDL's new focus will include tissue engineering and developmental biology -- in addition to some industrial applications.

"We are reacting to customers who have realized that the superior image definition provided by our patented multi-beam OCT technology is very advantageous in their applications", said MDL CEO Jon Holmes. "For a given depth of focus, you get twice the resolution, (or, for a given resolution, four times the focal depth), compared with single-beam OCT systems -- which means crisper, clearer images." He cited research on stem cells and dental applications among other examples.

The company currently markets the EX1301 OCT microscope, which it says is the only commercially available OCT product with < 10 μm lateral resolution, by virtue of its multi-beam optical design.

Holmes emphasizes that medical imaging remains a central objective of MDL. "We are developing clinical products for launch in 2009," he said, "and we are looking for business partners with experience in other fields to collaborate with or license to, allowing us to maintain our focus on cancer."

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

NIR spectroscopy intravascular imaging system receives $25M investment

Medical device maker Infraredx has received a $25 million equity investment from Nipro Corporation, which builds on an exclusive agreement between the two companies for distribution of Infraredx's ...

OCT pioneer Fujimoto selected as 2014 IEEE Photonics Award winner

James Fujimoto, the Elihu Thomson Professor of Electrical Engineering at the Massachusetts Institute of Technology (MIT), has been selected for the 2014 IEEE Photonics Award.

OCT combo system receives FDA clearance, begins shipping worldwide

Ophthalmic device maker Optovue has received FDA 510(k) clearance for its iFusion combination system, which pairs the company's iVue spectral-domain optical coherence tomography (SD-OCT) system and...

OCT symposium emphasizes key applications

Overviews of biomedical imaging in general, and optical coherence tomography (OCT) in particular, kicked off the first international symposium hosted last week by the Center for Biomedical OCT Rese...


Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...



Twitter- BioOptics World

Copyright © 2007-2016. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS